Drug Shortage Report for ACETYLCYSTEINE SOLUTION USP
Report ID | 55518 |
Drug Identification Number | 02459906 |
Brand name | ACETYLCYSTEINE SOLUTION USP |
Common or Proper name | Acetylcysteine Solution USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ACETYLCYSTEINE |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INTRAVENOUS ORAL |
Packaging size | 10 mL |
ATC code | R05CB |
ATC description | EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-02-12 |
Estimated end date | 2018-08-29 |
Actual end date | 2018-08-29 |
Shortage status | Resolved |
Updated date | 2018-09-04 |
Company comments | Alveda DIN 02300435 Acetylcysteine Injection 200 mg/mL is discontinued. Product will be available as Teligent DIN 02459906 Acetylcysteine Solution USP will be in stock July 22 2018. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-07-12 | English | Compare |
v2 | 2018-07-12 | English | Compare |
v3 | 2018-07-12 | English | Compare |
v4 | 2018-07-12 | French | Compare |
v5 | 2018-08-10 | English | Compare |
v6 | 2018-08-10 | French | Compare |
v7 | 2018-08-22 | English | Compare |
v8 | 2018-08-22 | French | Compare |
v9 | 2018-09-04 | English | Compare |
v10 | 2018-09-04 | French | Compare |
Showing 1 to 10 of 10